Physician profile
Gordon G Mitchell
NPI 1740258508
$10,239.65
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $1,345 · 2021: $1,830 · 2022: $1,786 · 2023: $2,027 · 2024: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,533.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,466.54 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,419.00 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $932.92 | 2019-2024 | |
| Medtronic, INC. | $844.45 | 2022-2024 | Azure Xt Dr Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $799.90 | 2019-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $470.86 | 2019-2022 | |
| Medtronic Vascular, INC. | $428.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $389.40 | 2021-2024 | Verquvo |
| Baxter Healthcare | $372.65 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $345.19 | 2020-2022 | |
| Abbott Laboratories | $329.59 | 2020-2024 | Aveir, Confirm Rx |
| Pfizer INC. | $313.11 | 2020-2024 | |
| Boston Scientific Corporation | $242.64 | 2021-2024 | Lux-Dx Insertable Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $213.46 | 2019-2022 | |
| Amarin Pharma, INC. | $177.36 | 2019-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $135.14 | 2019-2023 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $131.12 | 2019 | |
| Angiodynamics, INC. | $118.05 | 2023 | Auryon Laser System 100-120 Vac |
| Kestra Medical Technology Services, INC. | $116.91 | 2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $111.96 | 2022-2024 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $98.39 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $74.30 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.46 | 2019-2023 | Jardiance |
| Abiomed | $66.85 | 2022-2024 | Impella |
| Arbor Pharmaceuticals, INC. | $65.19 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $54.03 | 2022-2023 | Arcalyst |
| Chiesi USA, INC. | $50.24 | 2020-2021 | |
| Novo Nordisk INC | $47.53 | 2024 | Rybelsus, Ozempic |
| Vital Connect, INC | $41.51 | 2024 | Vitalpatch Rtm |
| Atricure, INC. | $39.70 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.15 | 2024 | Uptravi |
| Kowa Pharmaceuticals America, INC. | $31.40 | 2021-2022 | |
| Tactile Systems Technology INC | $28.03 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Medicomp INC | $27.98 | 2024 | Telepatch Cardiac Monitor |
| Lexicon Pharmaceuticals, INC. | $26.34 | 2023 | Inpefa |
| Nuwellis, INC. | $25.85 | 2020 | |
| Daiichi Sankyo INC. | $22.81 | 2024 | Injectafer |
| Terumo Medical Corporation | $19.10 | 2023 | Angio-Seal, Glidewire, Glidesheath Slender |
| Cvrx, INC. | $18.33 | 2024 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $13.55 | 2023 | Artis Icono Biplane |
| Avinger INC. | $13.55 | 2021 | |
| Edwards Lifesciences Corporation | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.